Cognitive-behavioral interventions improve quality of life in women with AIDS

Journal of Psychosomatic Research

Volumn 54, Issue 3, 2003, Pages 253-261

  Lechner, Suzanne C ^a   Antoni, Michael H ^a   Lydston, David ^a   LaPerriere, Arthur ^a   Ishii, Mary ^a   Devieux, Jessy ^a   Stanley, Heidi ^a   Ironson, Gail ^a   Schneiderman, Neil ^a   Brondolo, Elizaeth ^c   Tobin, Jonathan N ^b   Weiss, Stephen ^a  

^a Department of Biology   (United States)

^b Clinical Directors Network   (United States)

^c NONE

Author keywords

AIDS; Cognitive behavioral; Intervention; Minority women; Quality of life

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITION; COGNITIVE THERAPY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENERGY; FATIGUE; FEMALE; FOLLOW UP; GROUP THERAPY; HEALTH; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INDIVIDUALIZATION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MENTAL HEALTH; OUTCOMES RESEARCH; PAIN; PATIENT EDUCATION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; ROLE PLAYING; SOCIAL INTERACTION; SOCIAL SUPPORT; STRESS; VIRUS LOAD; WELLBEING;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGED; BEHAVIOR THERAPY; COGNITIVE THERAPY; FATIGUE; FEMALE; HEALTH STATUS; HUMANS; INTERVENTION STUDIES; MENTAL HEALTH; MIDDLE AGED; MINORITY GROUPS; PATIENT EDUCATION; QUALITY OF LIFE; RELAXATION TECHNIQUES; STRESS, PSYCHOLOGICAL; TREATMENT OUTCOME;

EID: 0037349648     PISSN: 00223999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3999(02)00480-4     Document Type: Article

References (35)

1. Centers for Disease Control and Prevention. HIV/AIDS surveillance report volume 12. Available from: URL: http://www.cdc.gov/hiv/stats/hasrlink.htm Accessed July 10, 2001.
2. Sowell RL, Seals BF, Moneyham L, Demi A, Cohen L, Brake S. Quality of life in HIV-infected women in the south-eastern United States. AIDS Care 1997;9:501-12.
3. Ickovics JR, Rodin J. Women and AIDS in the United States: Epidemiology, natural history, and mediating mechanisms. Health Psychol 1992;11:1-16.
4. Schneiderman N, Antoni MH, Ironson G. Cognitive behavioral stress management and secondary prevention in HIV/AIDS. Psychol AIDS Exch 1997;22:1-8.
5. Antoni MH, Schneiderman N. HIV and AIDS. In: Bellack AS, Hersen M, editors. Comprehensive Clinical Psychology. New York: Elsevier, 1998 pp. 237-75.
6. Kelly J. Group psychotherapy for persons with HIV and AIDS-related illnesses. Int J Group Psychother 1998;98:143-62.
7. Sikkema KJ, Kelly JA. Behavioral medicine interventions can improve the quality-of-life and health of persons with HIV disease. Ann Behav Med 1996;18:40-8.
8. Cella DF, McCain NL, Peterman AH, Mo F, Wolen D. Development and validation of the Functional Assessment of Human Immunodeficiency Virus Infection (FAHI) quality of life instrument. Qual Life Res 1996;5:450-63.
9. Wu AW, Rubin HR, Mathews WC, Ware JE, Brysk LT, Hardy WD, Bozzette SA, Spector SA, Richman DD. A health status questionnaire using 30 items from the Medical Outcomes Study: Preliminary validation in persons with early HIV infection. Med Care 1991;29:786-98.
10. Lutgendorf S, Antoni MH, Ironson G, Klimas N, Kumar M, Starr K, McCabe P, Cleven K, Fletcher MA, Schneiderman N. Cognitive-behavioral stress management decreases dysphoric mood and herpes simplex virus-type 2 antibody titers in symptomatic HIV-seropositive gay men. J Consult Clin Psychol 1997;65:31-43.
11. Antoni MH, Baggett L, Ironson G, LaPerriere A, August S, Klimas N, Schneiderman N, Fletcher MA. Cognitive-behavioral stress management buffers distress responses and immunologic changes following notification of HIV-1 seropositivity. J Consult Clin Psychol 1991;59:906-15.
12. Chesney MA, Folkman S, Chambers D. Coping effectiveness training for men living with HIV: Preliminary findings. Int J STDs AIDS 1996;7:75-82.
13. Weiss SM, Schneiderman N, Tobin J, LaPerriere A, Jones DL, Goldstein A, Chesney MA. Assisting Disempowered Women with AIDS. Boston: American Psychological Association, 1999.
14. O'Connor MF, Yalom ID, editors. Treating the Psychological Consequences of HIV. San Francisco: Jossey-Bass, 1997.
15. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morb Mort Wkly Rep 1992;41:1-35.
16. Power C, Selnes O, Grim J, McArthur J. HIV Dementia Scale: A rapid screening test. J AIDS Hum Retroviruses 1995;8:273-8.
17. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
18. Karnofsky D, Abelmann W, Craver L, Burchenal J. The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer 1948;1:634-52.
19. Spitzer RL, Williams JB, Gibbon M, First MB. Structured Clinical Interview for DSM-IIIR-Nonpatient Version for HIV Studies. New York: New York State Psychiatric Institute Biometrics Research Department, 1988.
20. Schwartz CE, Chesney MA, Irvine J, Keefe FJ. The control group dilemma in clinical research: Applications for psychosocial and behavioral medicine trials. Psychosom Med 1997;59:362-71.
21. Ironson G, Antoni M, Schneiderman N, LaPerriere A, Klimas N, Lutgendorf S, Fletcher MA. Stress management interventions and psychosocial predictors of disease course in HIV-1 infection. In: Goodkin K, editor. Psychoneuroimmunology: Stress, Mental Disorders and Health. Washington (DC): American Psychiatric Press, 1999. pp. 317-56.
22. Meichenbaum D. Cognitive Behavior Modification: An Integrative Approach. New York: Plenum, 1977.
23. Diamond S, Gore-Felton C, Gale DA, Classen C, Spiegel D. Supportive-Expressive Group Therapy for Persons with HIV Infection: A Treatment Manual. Stanford (CA): Stanford Press, 1997.
24. Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive Therapy of Depression: A Treatment Manual. New York: Guilford, 1979.
25. Levine SH, Bystritsky A, Baron D, Jones LD. Group psychotherapy for HIV-seropositive patients with major depression. Am J Psychother 1991;45:413-24.
26. LaPerriere A, Lechner S, Ishii M, Devieux J, Lydston D, Brondolo E, Ironson G, Antoni M, Tobin J, Schneiderman N, Weiss S. Decrease in depression maintained six-months following CBSM+ group intervention in women with AIDS: The SMART/EST women's project. Citation Award. Ann Behav Med 2000;22:S116.
27. Wu AW, Jacobsen D, Grant D, Scott-Lennox J. Quality of life scores predict clinical trial attrition and mortality. Programs and Abstracts of the 4th Conference on Retroviruses and Opportunistic Infections (Abstract No. 674), Washington, DC, January 1997.
28. Wu AW, Hays RD, Kelly S, Malitz F, Bozzette SA. Applications of the medical outcomes study health-related quality of life measures in HIV/AIDS. Qual Life Res 1997;6:531-53.
29. Wolff N, Helminiak T, Tebes JK. Getting the cost right in cost-effectiveness analyses. Am J Psychiatr 1997;154:736-43.
30. Yalom ID. The Theory and Practice of Group Psychotherapy. 4th ed. New York: Basic Books, 1995.
31. Lutgendorf SK, Antoni MH, Ironson G, Starr K, Costello N, Zuckerman M, Klimas N, Fletcher M, Schneiderman N. Changes in cognitive coping skills and social support during cognitive behavioral stress management intervention and distress outcomes in symptomatic human immunodeficiency virus (HIV)-seropositive gay men. Psychosom Med 1998;60:204-14.
32. Swindells S, Mohr J, Justis JC, Berman S, Squier C, Wagener MM, Singh N. Quality of life in patients with human immunodeficiency virus infection: Impact of social support, coping style and hopelessness. Int J STD AIDS 1999;10:383-91.
33. Friedland J, Renwick R, McColl M. Coping and social support as determinants of quality of life in HIV/AIDS. AIDS Care 1996;8:15-31.
34. Moneyham L, Hennessey M, Sowell R, Demi A, Seals B, Mizuno Y. The effectiveness of coping strategies used by HIV-seropositive women. Res Nurs Health 1998;21:351-62.
35. Antoni MH, Lehman JM, Kilbourn KM, Boyers AE, Culver JL, Alferi SM, Yount SE, McGregor BA, Arena PL, Harris SD, Price AA, Carver CS. Cognitive-behavioral stress management intervention decreases the prevalence of depression and enhances benefit-finding among women under treatment for early-stage breast cancer. Health Psychol 2001;20:20-32.